Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 57.01

From 52W high−26.83%

Volume15.98M

Market capCNY 42.33B

P/E (TTM)47.7x

P/S (TTM)7.0x

Div yield0.22%

Key dataSep 18, 2026

Open

CNY 57.01

From 52W high

−26.83%

Volume

15.98M

Market cap

CNY 42.33B

ValuationView details →

P/E (Fwd)

68.7x

EV/EBITDA

41.4x

P/E (TTM)

47.7x

RSI (14)

61.2

MomentumView details →

1D Return

−9.58%

YTD Return

+1.22%

ValuationView details →

P/E (Fwd)

68.7x

P/E (TTM)

47.7x

EV/EBITDA

41.4x

EV/Sales

7.4x

P/S (TTM)

7.0x

P/B (TTM)

2.0x

ProfitabilityView details →

Gross Margin

26.64%

Net Margin

10.91%

EBITDA Margin

17.88%

ROE (TTM)

3.69%

ROA (TTM)

2.68%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

+8.65%

EPS YoY

+134.70%

FCF YoY

+19.07%

Revenue CAGR 3Y

−1.20%

EPS CAGR 3Y

−23.47%

EBITDA YoY

—

MomentumView details →

1D Return

−9.58%

YTD Return

+1.22%

1Y Return

−2.31%

RSI (14)

61.2

vs 50D SMA

+10.51%

vs 200D SMA

+9.72%

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

2.30x

Quick Ratio

2.28x

Div Yield

0.22%

Div Rate

CNY 0.13

Div Growth 1Y

−58.00%

EarningsView details →

EPS (Actual)

−CNY 0.53

EPS Surprise

−477.79%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.33

Avg Surprise (4Q)

−477.79%

Rev Surprise

−0.23%

Financials snapshotView financials →

Revenue (TTM)

7.28B

Net Income (TTM)

93.36M

Op. CF (TTM)

1.27B

Next earningsOct 22, 2026 →

Latest newsMore news →

China's Zhejiang Securities Regulatory Bureau issued warning letters and a prior notice of administrative penalty to Tigermed's actual controllers Ye Xiaoping and Cao Xiaochun over late disclosure of shareholding changes.9d ago

Tigermed reported a net loss of 413 million yuan attributable to shareholders for the first half of 2026, swinging from a profit of 383 million yuan a year earlier, while revenue grew 14.06% year-on-year to 3.708 billion yuan.23d ago

Similar companies

华测检测300012.SZ 富乐德301297.SZ 康龙化成300759.SZ 南网能源003035.SZ 华大基因300676.SZ 百普赛斯301080.SZ Find similar companies →

Latest newsMore news →

China's Zhejiang Securities Regulatory Bureau issued warning letters and a prior notice of administrative penalty to Tigermed's actual controllers Ye Xiaoping and Cao Xiaochun over late disclosure of shareholding changes.9d ago Tigermed reported a net loss of 413 million yuan attributable to shareholders for the first half of 2026, swinging from a profit of 383 million yuan a year earlier, while revenue grew 14.06% year-on-year to 3.708 billion yuan.23d ago